down arrow

Concord Biotech

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,660.00
59.35 (3.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 68.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Net Sales
770.20
697.97
580.58
Other Operating Income
0.00
0.00
0.00
Total Operating income
770.20
697.97
580.58
Raw Material Cost
184.05
128.87
123.73
Purchase of Finished goods
45.67
45.29
19.24
(Increase) / Decrease In Stocks
-52.70
-33.80
-19.40
Employee Cost
99.97
89.09
81.59
Power Cost
26.44
27.40
0.00
Manufacturing Expenses
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
150.87
143.84
161.18
Total Expenditure (Excl Depreciation)
454.30
400.69
366.35
Operating Profit (PBDIT) excl Other Income
315.90
297.28
214.23
Other Income
35.06
22.97
23.11
Operating Profit (PBDIT)
350.96
320.25
237.34
Interest
0.44
2.09
3.06
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
350.52
318.16
234.28
Depreciation
39.75
39.88
39.85
Profit Before Tax
312.61
281.29
192.72
Tax
79.75
70.76
49.81
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
231.02
207.51
144.63
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
231.02
207.51
144.63
Share in Profit of Associates
0.23
5.57
3.97
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
231.25
213.08
148.60
Equity Capital
10.46
10.46
10.46
Face Value
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
Diluted Earnings per share
7.26
7.41
7.4
Operating Profit Margin (Excl OI)
41.02%
42.59%
36.9%
Gross Profit Margin
45.51%
45.58%
40.35%
PAT Margin
29.99%
29.73%
24.91%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 10.35% vs 20.22% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is 8.53% vs 43.39% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 6.26% vs 38.77% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is -78.95% vs -31.70% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023

Compare Nine Monthly Results Of Concord Biotech With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
770.20
9,199.93
-8,429.73
-91.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
770.20
9,199.93
-8,429.73
-91.63%
Raw Material Cost
184.05
1,471.08
-1,287.03
-87.49%
Purchase of Finished goods
45.67
1,244.57
-1,198.90
-96.33%
(Increase) / Decrease In Stocks
-52.70
-93.01
40.31
43.34%
Employee Cost
99.97
1,989.92
-1,889.95
-94.98%
Power Cost
26.44
0.00
26.44
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
150.87
2,225.77
-2,074.90
-93.22%
Total Expenditure (Excl Depreciation)
454.30
6,838.33
-6,384.03
-93.36%
Operating Profit (PBDIT) excl Other Income
315.90
2,361.60
-2,045.70
-86.62%
Other Income
35.06
287.35
-252.29
-87.80%
Operating Profit (PBDIT)
350.96
2,648.95
-2,297.99
-86.75%
Interest
0.44
238.94
-238.50
-99.82%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
350.52
2,410.01
-2,059.49
-85.46%
Depreciation
39.75
405.66
-365.91
-90.20%
Profit Before Tax
312.61
2,007.79
-1,695.18
-84.43%
Tax
79.75
427.80
-348.05
-81.36%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
231.02
1,576.55
-1,345.53
-85.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
231.02
1,576.55
-1,345.53
-85.35%
Share in Profit of Associates
0.23
9.92
-9.69
-97.68%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
231.25
1,570.19
-1,338.94
-85.27%
Equity Capital
10.46
40.06
-29.60
-73.89%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
45.51%
26.20%
0.00
19.31%
PAT Margin
29.99%
17.14%
0.00
12.85%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 770.20 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 10.35% vs 20.22% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 231.25 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 8.53% vs 43.39% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 315.90 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 6.26% vs 38.77% in Dec 2023

Nine Monthly - Interest
Interest 0.44 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -78.95% vs -31.70% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.02%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023